Hims & Hers to sell Grail’s Galleri multi-cancer blood test via its digital health platform

Hims & Hers, a telehealth platform, has begun offering Grail's Galleri multi-cancer blood test through its digital health service. Galleri is a cell-free DNA screening test designed to detect multiple cancer types from a single blood draw. The partnership expands access to the test via Hims & Hers' existing patient base and distribution channels, marking a move by the telehealth vendor into cancer screening diagnostics.